{"id":"W4401364392","doi":"10.1093/oncolo/oyae181.020","title":"19 Phase II Trial of Ubamatamab in MUC16-Expressing SMARCB1-Deficient Renal Medullary Carcinoma and Epithelioid Sarcoma","year":2024,"lang":"en","type":"article","venue":"The Oncologist","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Epithelioid sarcoma; Cancer research; CD3; Mucin; SMARCB1; CD30; Pathology; Medicine; Biology; Antigen; CD8; Sarcoma; Immunohistochemistry; Immunology; Gene expression","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001167319,0.001267434,0.001791963,0.0004199364,0.0003993657,0.001043057,0.001001867,0.001530668,0.002869709],"category_scores_gemma":[0.0003887958,0.0004039339,0.001322674,0.0003218548,0.0006597969,0.0006372192,0.0003584167,0.00220926,0.0006996728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001111774,"about_ca_system_score_gemma":0.001459846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001100514,"about_ca_topic_score_gemma":0.00226754,"domain_scores_codex":[0.9996921,0.0000934215,0.00002100011,0.00005076827,0.00003533825,0.0001074229],"domain_scores_gemma":[0.9996024,0.00003956035,0.00006841815,0.00004098488,0.00003686162,0.0002119314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4149067,0.102749,0.00904742,0.002836718,0.002780835,0.001700547,0.0003799503,0.007687995,0.2074584,0.001898295,0.009705623,0.2388485],"study_design_scores_gemma":[0.3223939,0.6221906,0.0101191,0.00009986955,0.000614684,0.001168997,0.00009524441,0.003987487,0.02471497,0.0006431232,0.01392601,0.00004602873],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831842,0.006193252,0.001341852,0.0005754373,0.0003411187,0.004457032,0.001426948,0.0001917884,0.002288416],"genre_scores_gemma":[0.9863427,0.00237612,0.001504784,0.0007069549,0.0001259294,0.002987664,0.002356482,0.00002403127,0.003575256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002869709,"threshold_uncertainty_score":0.009600103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03657062688265229,"score_gpt":0.3470010378014646,"score_spread":0.3104304109188123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}